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Abstract
Background: Acute myocardial infarction (AMI) is one of the more frequent reasons diabetic patients are admitted
to hospital, and there are reports that the long-term prognosis after an AMI is much worse in these patients than
in non-diabetic patients. This study aims to compare hospital admissions and costs in Spanish diabetic and non-
diabetic subjects due to AMI during the period 2001-2006.
Methods: We conducted a retrospective study of 6 years of national hospitalization data associated with diabetes
using the Minimum Basic Data Set. National hospitalization rates were calculated for AMI among diabetic and non-
diabetic adults. Fatality rates, mean hospital stay and direct medical costs related to hospitalization were analyzed.
Costs were calculated using Diagnosis-Related Groups for AMI in diabetics and non-diabetics patients.
Results: During the study period, a total of 307,099 patients with AMI were admitted to Spanish hospitals. Diabetic
patients made up 29.6% of the total. The estimated incidence due to AMI in diabetics increased from 54.7 cases
per 100,000 in 2001 to 64.1 in 2006. Diabetic patients had significantly higher mortality than nondiabetic patients
after adjusting for age, gender, and year (OR 1.11 [95% CI, 1.08-1.14]). The cost among diabetic patients increased
by 21.3% from 2001 to 2006.
Conclusions: Diabetic patients have higher rates of hospital admission and fatality rates during the hospitalization
after an AMI than nondiabetic patients. Diabetic adults who have suffered an AMI have a greater than expected
increase in direct hospital costs over the period 2001-2006.
Background
The prevalence of diabetes in Spain has increased dur-
ing the last 10 years. A recent review shows that it var-
ies from 10% to 15% [1] according to the study,
population, and diagnostic method. Other group shows
that the prevalence of diabetes in Spain in individuals
aged < 65 years is approximately 6%, a percentage that
increases with age [2].
In Spain, the Diabetes Strategy of the National Health
System (Ministry of Health and Consumer Affairs) cal-
culates the mortality rate of diabetes to range from
12.75 to 30.37 deaths per 100,000 inhabitants per year.
Coronary disease is the main cause of death among dia-
betes patients, and 75% of patients with diabetes die
mainly of coronary disease [3].
Cardiovascular disease and diabetes are clearly related.
Indeed, several cohort studies show that diabetic
patients are at greater risk of experiencing a coronary
event than the general population [4,5]. Therefore, as a
complication of diabetes, cardiovascular disease is asso-
ciated with a greater proportion of direct costs [6]. Gan-
dra et al (2006) showed that health care costs triple in
diabetic patients with cardiovascular complications [7].
Acute myocardial infarction (AMI) is one of the rea-
sons diabetic patients with cardiovascular complications
are admitted to hospital, and there are reports that the
long-term prognosis after an AMI is much worse in dia-
betic patients than in nondiabetic patients [8,9]. In fact,
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diabetic patients [9].
However, despite the association between diabetes and
AMI, few studies quantitatively assess the role of dia-
betes in the morbidity, mortality, and hospital costs of
coronary disease. In the present study, we aim to deter-
mine how hospital costs and mortality in Spain evolve
in diabetic patients admitted with AMI between 2001
and 2006.
Methods
A retrospective, descriptive, epidemiologic study was
conducted, using the Minimum Basic Data Set (MBDS)
as the data source. The MBDS is a national hospital
admission database containing discharge data abstracted
for at least 95% of all Spanish acute care hospitaliza-
tions. It is managed by the Spanish Ministry of Health
and Consumer Affairs [10] and includes the following
data: hospital details; patient’s name, date of birth, gen-
der, place of residence, and date of admission; surgical
and obstetric procedures; other procedures; and date
and type of discharge.
Diagnostic coding was based on the International
Classification of Diseases (ICD-9-CM). Each contact is
recorded with one o more diagnosis code in ICD-9-CM.
Myocardial infarction was defined by the main medical
diagnosis with codes 410.0-410.9. Patients were then
further defined by presence/absence of diabetes (ICD-9-
CM code 250) using secondary medical diagnosis (in
any of its 13 sections).
Incidence of hospitalization due to AMI among sub-
jects with or without diabetes was calculated using the
Spanish National Statistics Institute census projections
from the year 2001 [11].
Mean hospital stay due to AMI in patients with and
without diabetes was calculated overall and by age
group. We also analyzed mortality during hospitalization
among patients with and without diabetes.
The direct costs to the National Health System were
calculated using Diagnosis-Related Groups (DRG) for
this disease. According to the DRG reimbursement sys-
tem, every hospitalized patient belongs to a group of
diagnostically homogeneous cases; therefore, patients
within each category are similar in clinical terms, and
are expected to use the same level of hospital resources.
As a result, patients in the same DRG are assigned the
same reimbursement charges [10].
We use a specific DRG for AMI (DRG 121: CIRCU-
LATORY DISORDERS W AMI & MAJOR COMP, DIS-
CHARGED ALIVE) and for diabetes (DRG 294:
DIABETES AGE >35) (All patients -DRG version 22.0)
[10].
In order to calculate the cost per patient above the
Retail Price Index (RPI), we used the RPI section of the
Spanish National Statistics Institute web page. The RPI
measures the development of prices of goods and ser-
vices consumed in Spain [12].
The cost per patient without diabetes was aged and
sex adjusted using the diabetic population as a refer-
ence. Quantitative variables were expressed as the mean
± standard deviation and qualitative variables were
expressed as frequencies. The chi-square test was used
to compare categorical variables, and t tests and an
ANOVA to compare means. Statistical significance was
set at P < 0.05 (two-tailed). To compare the incidence
of AMI for patients with and without diabetes, and the
time course for both groups, we used multivariate Pois-
son regression analysis. We used logistic regression
models to analyze mortality. The logistic regression
multivariate model was built using the “enter modelling”
method.” The dependent variable was death (yes/no)
and the independent variables included: year, sex and
age.
All statistical analyses were performed using the Stata
statistics computer software package.
Results
A total of 307,099 patients with AMI were admitted to
Spanish hospitals covered by the MBDS during the 6-
year study period. The mean age was 68.5 ± 13.1 years
(median 71 years), and 69% were men. Diabetic patients
made up 29.6% of the total (90,835).
Table 1 shows the annual hospital admission rates
according to gender, for both diabetics and nondiabetics
subjects. These rates increased until 2003, when they
began to fall: the mean stay fell from 10.4 days in 2001
to 9.6 days in 2006 for diabetic patients (p ≤ 0.05), and
from 9.8 days in 2001 to 8.4 days in 2006 for nondia-
betic patients (p ≤ 0.05). During admission, 12.4% of
diabetics adults and 9.9% of nondiabetics died (p ≤
0.05).
The incidence of hospital admissions due to AMI in
diabetic subjects increased from 54.7 cases per 100,000
inhabitants in 2001 to 64.1 cases per 100,000 inhabitants
in 2006. Mean stay decreased significantly (10.3 ± 8.0
days for diabetic men and 10.5 ± 9.1 days for diabetic
women in 2001 compared with 9.4 ± 8.8 days for dia-
betic men and 9.9 ± 8.3 days for diabetic women in
2006), as did fatality rate (10.7% in diabetic men and
16.7% in diabetic women in 2001 compared with 9.0%
in diabetic men and 14.5% in diabetic women in 2006).
By age group, incidence increased with age in diabetic
patients (17.7 per 100,000 inhabitants for aged 35-60
years vs. 205.4 per 100,000 inhabitants for aged over 81
years) and was greater for men in every year. During
each year of the study, the mean stay was greater in dia-
betic women than men. Fatality rate was greater in dia-
betic women than men in all age groups.
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sis. After controlling for possible confounders, we
observed that the incidence of admissions among dia-
betic patients increased significantly during the 6-year
study period (IRR 1.16 95% CI 1.14-1.19). Diabetic
patients had significantly higher mortality than nondia-
betic patients after adjusting for age, gender, and year
(OR = 1.11; 95% CI, 1.08-1.14), and mortality among
diabetic patients increased significantly with age and fell
during the study period. Mortality was significantly
greater in diabetic women than in men (OR = 1.22;95%
CI, 1.17-1.28).
Table 3 presents how the hospitalization costs for
AMI evolved during the study period in diabetic and
non-diabetic patients. Using the DRG for the study dis-
eases, the estimated cost per diabetic patient and year
was €4,440 in 2001 and €6,228 in 2006 (total cost was
€54,334,000 in 2001 and €98,075,000 in 2006). The cost
of admissions for diabetic patients increased significantly
(p ≤ 0.05) along the study period. When the RPI effect
was eliminated, the cost in diabetic patients increased
by 19.5% from 2001 to 2006.
The cost per patient without diabetes has also
increased across the study period from €4,625 in 2001
to €6,283 in 2006. The cost was higher among those
without versus those with diabetes in all the years of the
study. When the RPI effect was eliminated, the cost in
non-diabetic patients increased by 28,2% from 2001 to
2006.
Discussion
Main Findings
Our results show that approximately 30% of Spanish
adults who experience an AMI have an associated diag-
nosis of diabetes. The results of the 1998 PREVESE
study revealed that 22.6% of patients admitted to hospi-
tal for AMI were diabetics [13]. This discrepancy with
our results could be explained by the fact that the pre-
valence of diabetes has increased in Spain during the
last 10 years [1].
These results are also consistent with those of Fang et
al (2006), who showed that the hospital workload gener-
ated by AMI is greater in diabetic patients than in non-
diabetic patients [14].
Table 1 Hospital admissions by acute myocardial infarction among subjects with or without diabetes for years 2001-
2006.
With Diabetes Without Diabetes
Year Sex Total Inc.* M.S. (SD)† %F.R. † Total Inc.* M.S. (SD)† %F.R. †
2001 Men 7,030 66.5 10.3(8.0) 10.7 25,127 237.7 9.6(10.1) 9.2
Female 5,206 44.1 10.5(9.1) 16.7 9,016 76.3 9.8(8.99 16.7
Both 12,236 54.7 10.4(8.4) 13.2 34,143 152.5 9.8(9.4) 11.2
2002 Men 8,066 75.9 10.5(9.1) 11.1 26,945 253.5 9.7(9.6) 8.6
Female 5,802 48.9 10.6(9.0) 17.5 9,970 84.1 9.9(9.2) 15.7
Both 13,868 61.7 10.5(9.1) 13.8 36,915 164.2 9.7(9.5) 10.5
2003 Men 9,332 85.6 10.3(8.7) 10.2 26,927 247.1 9.2(8.6) 8.5
Female 6,636 54.7 10.4(9.5) 16.6 9,966 82.2 9.3(8.3) 15.4
Both 15,968 69.4 10.3(9.1) 12.9 36,893 160.3 9.2(8.5) 10.3
2004 Men 9,685 86.7 9.8(8.1) 9.6 26,833 240.2 9.0(9.8) 7.7
Female 6,716 54.2 10.2(8.4) 15.0 9,726 78.5 9.3(11.5) 15.2
Both 16,401 69.6 9.9(8.2) 11.8 36,559 155.2 9.0 (10.3) 9.7
2005 Men 10,026 87.7 9.6(8.5) 10.2 26,369 230.6 8.6(8.8) 7.5
Female 6,582 52.0) 9.9(8.2) 15.1 9,819 77.6 9.2(8.5) 13.8
Both 16,608 69.0 9.7(8.4) 12.1 36,188 150.3 8.8(8.7) 9.2
2006 Men 9,659 82.5 9.4(8.8) 9.0 26,038 222.6) 8.3(8.3) 6.8
Female 6,095 47.2 9.9(8.3) 14.5 9,528 73.8 8.7(8.7) 13.2
Both 15,754 64.1 9.6(8.6) 11.2 35,566 144.6 8.4(8.4) 8.5
Total Men 53,798 81.0 10.0(8.6) 10.1 158,239 238.3 9.2(9.1) 8.0
Female 37,037 50.2 10.3(8.7) 15.9 58,025 78.6 9.5(9.3) 15.0
Both 90,835 64.8 10.1(8.7) 12.4 216,264 154.4 9.2(9.2) 9.9
*Inc: Incidence per 100,000. Incidence was calculated using the Spanish National Statistics Institute census projections from the year 2001.
†M.S. (SD): Mean Stay (Standard Deviation). %F.R.: Fatality rate.
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quence of AMI decreased in both diabetic and nondia-
b e t i cp a t i e n t s .B o o t he ta l( 2 0 0 6 )s h o w e dt h a tb o t h
diabetics and nondiabetics who have experienced an
AMI have lower mortality rates over time, suggesting
that the care and management of AMI patients have
improved in recent years [15].
After adjusting for age and gender, we observed that
the in-hospital mortality for diabetic patients who have
experienced an AMI is significantly greater (11%) than
for nondiabetic patients. Several studies report that
diabetics who experience an AMI have higher fatality
rates than nondiabetics [4,5,16]. This could be due to
the fact that these patients have a worse clinical status
than nondiabetics or are at a greater risk of complica-
tions [15].
The outcome of diabetic patients over time, both in
terms of admissions and in terms of mortality after AMI,
was less favorable in those aged ≥65 years than in
younger patients. Svensson et al (2007) showed that mor-
tality at 7 years post-AMI was 59.2% in diabetic patients
aged over 65 years and 46.3% in those aged 55-64 years
Table 3 Hospitalization costs among subjects who have suffered a myocardial infarction according to age groups and
year.
Year
Diabetic patients Age, years* 2001 2002 2003 2004 2005 2006
35-60 9,917 12,134 14,941 16,470 17,089 19,677
61-70 15,575 18,365 21,509 22,174 22,966 23,597
71-80 20,250 25,900 32,086 34,171 35,042 37,215
>81 8,590 11,213 14,253 16,458 17,525 17,584
Total 54,334 67,614 82,792 89,274 92,623 98,075
P/A 4,440 4,875 5,187 5,443 5,577 6,228
Difference above RPI ——— 297 132 111 -34 417
Non diabetic patients Age, years*
35-60 51,544 59,523 66,500 69,033 69,089 81,154
61-70 39,859 42,942 45,521 44,433 44,733 49,150
71-80 45,581 54,196 55,246 59,529 59,163 60,056
>81 22,583 29,075 30,669 33,342 35,405 37,109
Total 159,568 185,736 197,937 206,338 208,392 227,470
P/A 4,625 5,005 5,288 5,587 5,718 6,283
Difference above RPI ——— 211 150 125 -63 393
* Thousands of Euros. P/A: Total cost per patient and year (Euros). RPI: Retail Price Index
Table 2 Multivariate analysis of the factors associated with incidence and mortality after acute myocardial infarction.
Incidence (IRR)* Fatality (OR)
†
Diabetic patients Non diabetic patients Diabetic patients Non diabetic patients
Age (years) 35-60 1111
61-70 5.40 (5.29-5.51) 2.59 (2.56-2.62) 2.18 (1.98-2.40) 2.36 (2.22-2.51)
71-80 10.54 (10.35-10.79) 4.34 (4.29-4.38) 3.91 (3.57-4.27) 5.00 (4.74-5.27)
≥81 12.87 (12.59-13.15) 7.02 (6.94-7.11) 6.55 (5.98-7.18) 10.31 (9.77-10.82)
Sex Men 1111
Female 0.52 (0.51-0.52) 0.28 (0.28-0.28) 1.22 (1.17-1.28) 1.18 (1.14-1.22)
Year 2001 1111
2002 1.12 (1.10-1.15) 1.07 (1.05-1.09) 1.03 (0.96-1.11) 0.90 (0.85-0.94)
2003 1.26 (1.24-1.29) 1.04 (1.03-1.06) 0.93 (0.86-1.00) 0.88 (0.84-0.92)
2004 1.27 (1.24-1.30) 1.01 (0.99-1.02) 0.84 (0.78-0.90) 0.81 (0.77-0.86)
2005 1.26 (1.23-1.29) 0.97 (0.96-0.99) 0.86 (0.80-0.92) 0.76 (0.72-0.80)
2006 1.16 (1.14-1.19) 0.93 (0.92-0.95) 0.78 (0.73-0.84) 0.70 (0.66-0.74)
* Calculated using multivariate Poisson regression: Incidence Rate Ratios (IRR).
† Calculate using logistic regression models:Odds Ratio (OR). The logistic regression
multivariate model and Poisson regression model were built using as dependent variables “death (yes/no)” and “Incidence of AMI” respectively, and as
independent variables year, sex and age.
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hospital mortality due to AMI in diabetics aged over 65
years fell at a lower rate than in diabetic patients aged
less than 65 years [15].
The literature clearly shows that women have a lower
incidence of AMI than men [17,18]. However, hospita-
lized women have been reported to undergo fewer diag-
nostic or revascularization procedures, and therefore
h a v eah i g h e rm o r t a l i t yr a t e[ 1 9 ] .I no u rs t u d y ,d i a b e t i c
women had significantly higher mortality rates than dia-
betic men. These results are consistent with those of
other studies that specifically analyze the interaction
between gender and diabetes [9,18,19]. In the Secondary
Prevention Reinfarction Israeli Nifedipine Trial
(SPRINT) study, diabetes was a significant predictor of
hospital mortality after AMI in women, but not in men.
Also, in the US Second National Registry of Myocardial
Infarction, women were at greater risk of hospital death
than men, even after adjusting for comorbid conditions
and treatment differences. These data suggest that
hemodynamic and other mechanisms associated with
the onset of acute infarction may be compromised to a
greater extent in women than in men with diabetes
[20,21].
Our study revealed an inverse relationship between
mean hospital stay and costs over time in patients who
experienced an AMI. This could be due to several fac-
tors. First, recent advances in therapy have improved
reperfusion treatment and led to more widespread use
of antithrombotic drugs and diagnosis methods thus
reducing hospital stay while increasing costs [22]. Sec-
ond, 40% of deaths by AMI in Spain occur in patients
who do not reach hospital, but fortunately this percen-
tage is decreasing over time and therefore more severe
cases now reach the hospital and increase the cost [23].
Third, older age and prevalence of comorbid conditions
could also explain the increased costs of hospital stay
after an AMI [24].
Direct medical costs per patient did not differ signifi-
cantly between those with and without diabetes. Other
authors find that diabetes increases healthcare costs
among patients hospitalized with cardiovascular disease
[25].
In our population costs were mainly generated by
elderly patients (> 70 years), thus confirming the results
of previous studies, which show that patients aged over
65 years account for approximately two-thirds of all dia-
betes-associated medical costs [8].
Study Limitations
The strength of our study lies in its large sample size
and standardized methodology. Nevertheless, it does
present a series of limitations. First, our database was a
National Health Service data set of information on
hospital discharges; therefore, it contains scant clinical
information (eg, pharmacologic treatment is not
r e c o r d e d ) .T h ed a t ai nt h eM B D Sa r ea n o n y m o u s ,w i t h
the result that it is impossible to determine whether the
same patient was admitted more than once during the
same year. However, this data set, which was introduced
in Spain in 1982, is a mandatory register, and its cover-
age is estimated to be more than 95% [10]. Furthermore,
it provides useful information on hospital management
of AMI, since it brings together data from all admissions
due to AMI, regardless of the characteristics of the
attending hospital or the department to which the
patient is admitted.
Third, although the financial burden of diabetes in
patients admitted to hospital with AMI is considerable,
we feel that the real cost of diabetes is underestimated,
because many patients are not diagnosed as having dia-
betes, or diabetes is not included in the diagnosis on
admission [25].
A complete classification of cases in type 1 and type 2
diabetes is not possible based on the information avail-
able in registers; hence the type of diabetes is not con-
sidered in this report.
Costs were calculated using the DRG for the disease.
Although DRG have been widely used as a patient clas-
sification system for hospital cost analysis, they present
a series of limitations [26], including significant internal
variability in comorbid conditions and a lack of sensitiv-
ity for different medical practices used in similar dis-
eases. In addition, the indication for diagnosis and
therapeutic procedures has not always been evaluated
[26].
Conclusions
Our study provides updated information on the impact
of AMI in diabetic patients and nondiabetic patients,
and on the costs associated with admissions to hospital
due to this condition over a 6-year period in Spain.
In Spain the continuing increase in the prevalence of
diabetes and the lack of improvement in the control of
cardiovascular risk factors and health-related behaviors
call for greater dedication on the part of persons with
diabetes and the health care community [1-3,13,27].
More effective interventions to improve this situation
are clearly needed and could include: empowering
patients with information to improve the quality of care
they receive, their lifestyles and health outcomes; and
ongoing monitoring and measurement of cardiovascular
risk factors and unhealthy behaviors [1-3,13,27]. Only
improving the education, prevention and quality of care
we could reduce the incidence, mortality and burden of
AMI among Spanish diabetes sufferers [1-3,13,27].
We conclude that diabetic patients have higher rates
of hospital admission and fatality rates during the
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Page 5 of 6hospitalization after an AMI than nondiabetic patients,
Diabetic adults who have suffered an AMI have a
greater than expected increase in direct hospital costs
over the period 2001-2006.
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